What is the Impact Factor of Cancer Biology & Medicine?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cancer Biology & Medicine is 12.4, ranking in quartile Q1 of Web of Science (SCIE).

Is Cancer Biology & Medicine indexed in Web of Science or Scopus?

Yes, Cancer Biology & Medicine is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.888 (Q1) and an H-index of 78.

Who publishes Cancer Biology & Medicine and what is the Article Processing Charge (APC)?

Cancer Biology & Medicine is published by Chinese Anticancer Association. The estimated Article Processing Charge (APC) is approximately $3,595 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cancer Biology & Medicine?

The official ISO-4 abbreviation of Cancer Biology & Medicine is "CANCER BIOL MED" with common acronym "cbm". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #1,613Gold OADomestic Journal

Cancer Biology & Medicine

Acronym:cbm

•

Abbreviation (ISO):CANCER BIOL MED

•

Identifier (ISSN):2095-3941(Print)

•

Publisher:Chinese Anticancer Association

Official Website Submission Portal Compare

Clarivate IF (2026)

12.4↑ +4

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cancer Biology & Medicine

WoS Q1

Annual Impact Factor Metric

Current (2026):12.4

Scopus SJR & RankScopus Q1

1.888

#1,613

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

78 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation Rate14.3%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

136articles/year

100% Gold OA•58.14% Original Research

Aims & Scope

Cancer Biology & Medicine (ISSN 2095-3941) is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China.

Topics Covered (Recognized by AI)

Medicine99.4%Biology98.8%Genetics95.7%Internal medicine94.2%Cancer71.2%Chemistry65.6%Biochemistry61.6%Cancer research57.3%Pathology54%Oncology42.7%Gene41.9%Immunology38.3%Surgery34.7%Physics21.6%Radiology21.5%Mathematics20.8%Cell biology20.5%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank16/191

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank27/333

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank34/191

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank59/333

IndexSCIE

Category	Index	Rank	Quartile
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	16/191	Q1
ONCOLOGY	JCRSCIE	27/333	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	34/191	Q1
ONCOLOGY	JCISCIE	59/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF12.4

Articles / Year108

Total Citations51

2025

IF8.4

Articles / Year120

Total Citations482

2024

IF5.6

Articles / Year85

Total Citations1,066

2023

IF5.5

Articles / Year95

Total Citations1,528

2022

IF5.347

Articles / Year60

Total Citations1,584

Year	Impact Factor	Articles / Year	Total Citations
2026	12.4	108	51
2025	8.4	120	482
2024	5.6	85	1,066
2023	5.5	95	1,528
2022	5.347	60	1,584
2021	4.248	154	4,007
2020	5.432	80	4,204
2019	4.467	72	3,169
2018	4.607	85	1,675
2017	—	47	4,118
2016	—	51	2,860
2012	—	1	7

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,613Scopus Q1SCImago Profile

Scopus Coverage:2012-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

1.888

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

7.03

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,595 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,022

3-Year Documents305

Citable Documents253

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 14.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

2区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Biology & Medicine (acronym: cbm, abbr: CANCER BIOL MED, ISSN: 2095-3941) is a peer-reviewed international scholarly journal in the field of Medicine, published by Chinese Anticancer Association in China since 2012. The periodical holds a Journal Impact Factor (JIF) of 12.4, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.888 (Q1), an H-index of 78.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 136 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,595 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.